A randomized, prospective, pharmacoecono
β
Surendra Shenoy; Karen L. Hardinger; Jeffrey Crippin; Kevin Korenblat; Mauricio
π
Article
π
2008
π
John Wiley and Sons
π
English
β 293 KB
π 1 views
Two-hour postdose cyclosporine (C2) monitoring is becoming an accepted method of therapeutic drug monitoring, although it is not known whether C2 monitoring is superior to tacrolimus (FK)-based immunosuppression. The purpose of this trial was to compare the safety, efficacy, and pharmacoeconomics of